A carregar...
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
AIM: Sacubitril-valsartan has proven beneficial in heart failure with reduced ejection fraction. Guidelines recommend initiating half-dose sacubitril-valsartan before up-titration even to patients already on target dose angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers...
Na minha lista:
| Publicado no: | Cardiovasc Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6739794/ https://ncbi.nlm.nih.gov/pubmed/31772613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6745074 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|